Skip to main content
Premium Trial:

Request an Annual Quote

MWG Says It Successfully Opposed Applera Nucleic Acid Amplification Patent

NEW YORK, March 18 - (GenomeWeb News) - MWG Biotech said today that it was successful in opposing a European patent held by Applera over a patent for nucleic acid amplification.

 

The company, based in Ebersberg, Germany, said the European Patent Office revoked Applera's European Patent No. 236 069 B1, entitled "Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps," after MWG and others had opposed the patent.

 

This decision, the company said, is final. "There are no further judicial remedies," MWG said in a statement.

 

Applera had not issued any public statement on this matter.

 

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.